Global Synthetic Biology Market By Offerings (Products/Systems (DNA synthesis, Enzymes, Gene Fragment, Algae Engineering Kits, Synthetic Cells, Others), Software, Services), By Technology (Cloning, Gene Synthesis, Microfluidic, Genome Engineering, Site-Directed Mutagenesis, Sequencing, Others), By Application (Food and Beverages, Medical Application (Therapeutics, Drug Discovery, Vaccine production, Life Science Research, Others), Agriculture, Cosmetic and Personal care, Industrial and Automation, Chemicals, Renewable Energy, Environment, Others), By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
Synthetic biology is an engineering and science interdisciplinary field that tries to redesign and create novel artificial biological pathways or synthetic biomolecules. It has been defined as a revolutionary technology at the centre of the bioeconomy, capable of offering innovative solutions to global healthcare, agriculture, manufacturing, and environmental concerns. Synthetic biology is propelling enormous discoveries in biomedicine, which will result in game-changing improvements in healthcare. Many of the challenges of synthetic biology have been overcome by the recent development of efficient design and modeling-related computer tools, enhanced DNA synthesis and assembly methods to build complex DNA constructs, and cutting-edge next-generation sequencing technologies. Furthermore, the increasing demand for synthetic biology for research and development activities by biotechnological and pharmaceutical businesses contributes to the expansion of this industry. According to the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), the pharmaceutical research-based sector spends about 149.8 billion USD per year on R&D. The major factors driving the synthetic biology market growth are assistance from government and private organizations, an increase in the number of synthetic biology research institutions, and a decrease in the cost of DNA sequencing and synthesizing. Furthermore, these organizations are investing heavily in synthetic biology research and development. Apart from massive investments being made in the synthetic biology area, the growing geriatric population and advanced, creative synthetic biology applications are also propelling this industry ahead globally.
The coronavirus disease 2019 was declared a pandemic in March 2020. Since then, the COVID-19 epidemic has caused an extraordinary demand for healthcare resources. The increased local prevalence of COVID-19 had a substantial impact on research activities. Government bodies and corporates invested in the science and technology space for the discovery of pharmaceuticals and synthetic biological products, particularly for the development of viable COVID-19 vaccines that are proving to be a major driver for the growth of this market. Furthermore, enhanced potential of innovation in synthetic biology systems of the future will provide new opportunities for market participants in the synthetic biology market to expand.
In terms of revenue, the global synthetic biology market was valued at US$ 9.7 Bn in 2021 growing at a CAGR of 27.6% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Synthetic Biology Market Revenue & Forecast, (US$ Million), 2015 – 2030
Offering Outlook
Based on offering, the global synthetic biology market has been primarily segmented into products/systems, software, and services. The products/systems segment is again bifurcated into DNA synthesis, enzymes, gene fragment, algae engineering kits, synthetic cells, and others. Among the segments, the DNA synthesis segment dominated the synthetic biology market in 2021. DNA synthesis is a key technique in molecular biology that is used in a variety of areas, including genetic engineering and clinical diagnosis/treatment.
Technology Outlook
Based on technology, the global synthetic biology market has been segmented into cloning, gene synthesis, microfluidic, genome engineering, site-directed mutagenesis, sequencing, and others. The cloning segment registered for the largest share of the market in 2021 as it rapid, convenient, easily repeatable, extremely specific, and highly sensitive technology. Market participants such as Agilent Technologies, Inc. offer cloning kits, and the company offers everything from a traditional topoisomerase-based kit to a vast catalogue vector selection for any application. The StrataClone PCR Cloning Kit enables high-efficiency, 5-minute cloning of PCR results at room temperature by utilizing the effective DNA rejoining activity of DNA topoisomerase and the DNA recombination activity of Cre recombinase.
Application Outlook:
Based on application, the global synthetic biology market has been segmented into food and beverages, medical application, agriculture, cosmetic and personal care, industrial and automation, chemicals, renewable energy, environment, and others. Industrial and automation segment is one of the significant segments and accounts for a considerable share of the market. Synthetic biology technologies are quickly becoming the most cost-effective and ecologically friendly approach to develop almost anything. To remain competitive in the future, businesses use synthetic biology to develop new products and processes, improve existing ones, and cut costs. Industrial biotechnology, in particular, uses enzymes and microorganisms to produce bio-based products in industries such as chemicals, food ingredients, detergents, paper, and textiles.
Region Outlook:
Based on regions, Asia pacific region is projected to be the fastest growing region in the global synthetic biology market over the forecast years owing to the rising number of research entities and growing economies. Furthermore, increasing adoption of new technologies for research activities by pharmaceutical and manufacturing companies is supporting for the overall regional market's expansion to a great extent. Also, presence of major developing economies such as China and India is also contributing to the growth of the Asia pacific region in the coming years.
Competitive Landscape Outlook:
The report provides both, qualitative and quantitative research of the global synthetic biology market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global synthetic biology market are listed below:
- Agilent Technologies, Inc.
- Amyris
- Arzeda
- Codexis, Inc.
- GenScript
- Ginkgo Bioworks
- Illumina, Inc.
- Intrexon Corporation
- Royal Dutch Shell
- String Bio
- SynbiCITE
- Thermo Fisher Scientific
- Twist Bioscience
- ZYMERGEN INC.
- Other Market Participants
Global Synthetic Biology Market:
- By Offering
- Products/Systems
- DNA synthesis
- Enzymes
- Gene Fragment
- Algae Engineering Kits
- Synthetic Cells
- Others
- Software
- Services
- Products/Systems
- By Technology
- Cloning
- Gene synthesis
- Microfluidic
- Genome Engineering
- Site-Directed Mutagenesis
- Sequencing
- Others
- By Application
- Food and Beverages
- Medical Application
- Therapeutics
- Drug Discovery
- Vaccine Production
- Life Science Research
- Others
- Agriculture
- Cosmetic and Personal care
- Industrial and Automation
- Chemicals
- Renewable Energy
- Environment
- Others
- By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
- North America
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2021
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Synthetic Biology Market
6. Market Synopsis:
Synthetic Biology Market
7. Synthetic Biology Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
Synthetic Biology Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Synthetic Biology Market
7.6. Impact of
Covid-19 on Synthetic Biology Market
8. Global Synthetic Biology Market Analysis and Forecasts, 2022
– 2030
8.1. Overview
8.1.1. Global
Synthetic Biology Market Revenue (US$ Mn)
8.2. Global
Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Offerings
8.2.1. Products/Systems
(Definition, Market Estimation and Penetration, 2015 - 2021, Market Estimation
(2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on DNA synthesis, Enzymes, Gene
Fragment, Algae Engineering Kits, Synthetic Cells, Others)
8.2.1.1. DNA synthesis
8.2.1.2. Enzymes
8.2.1.3. Gene Fragment
8.2.1.4. Algae Engineering Kits
8.2.1.5. Synthetic Cells
8.2.1.6. Others
8.2.2. Software
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2021
8.2.2.3. Market Forecast, 2022 - 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 - 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 - 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 - 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 - 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 - 2030
8.2.3. Services
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2021
8.2.3.3. Market Forecast, 2022 - 2030
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2021
8.2.3.5.1.2. Market
Forecast, 2022 - 2030
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2021
8.2.3.5.2.2. Market
Forecast, 2022 - 2030
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2021
8.2.3.5.3.2. Market
Forecast, 2022 - 2030
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2021
8.2.3.5.4.2. Market
Forecast, 2022 - 2030
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2021
8.2.3.5.5.2. Market
Forecast, 2022 - 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offerings
9. Global Synthetic Biology Market Analysis and Forecasts, 2022
– 2030
9.1. Overview
9.2. Global
Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Technology
9.2.1. Cloning
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2021
9.2.1.3. Market Forecast, 2022 - 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 - 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 - 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 - 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 - 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 - 2030
9.2.2. Gene
synthesis
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2021
9.2.2.3. Market Forecast, 2022 - 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 - 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 - 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 - 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 - 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 - 2030
9.2.3. Microfluidic
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2021
9.2.3.3. Market Forecast, 2022 - 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 - 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 - 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 - 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 - 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 - 2030
9.2.4. Genome
Engineering
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2021
9.2.4.3. Market Forecast, 2022 - 2030
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2021
9.2.4.5.1.2. Market
Forecast, 2022 - 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2021
9.2.4.5.2.2. Market
Forecast, 2022 - 2030
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2021
9.2.4.5.3.2. Market
Forecast, 2022 - 2030
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2021
9.2.4.5.4.2. Market
Forecast, 2022 - 2030
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2021
9.2.4.5.5.2. Market
Forecast, 2022 - 2030
9.2.5. Site-Directed
Mutagenesis
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2021
9.2.5.3. Market Forecast, 2022 - 2030
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2021
9.2.5.5.1.2. Market
Forecast, 2022 - 2030
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2021
9.2.5.5.2.2. Market
Forecast, 2022 - 2030
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2021
9.2.5.5.3.2. Market
Forecast, 2022 - 2030
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2021
9.2.5.5.4.2. Market
Forecast, 2022 - 2030
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2021
9.2.5.5.5.2. Market
Forecast, 2022 - 2030
9.2.6. Sequencing
9.2.6.1. Definition
9.2.6.2. Market Estimation and Penetration, 2015 - 2021
9.2.6.3. Market Forecast, 2022 - 2030
9.2.6.4. Compound Annual Growth Rate (CAGR)
9.2.6.5. Regional Bifurcation
9.2.6.5.1. North America
9.2.6.5.1.1. Market
Estimation, 2015 - 2021
9.2.6.5.1.2. Market
Forecast, 2022 - 2030
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2021
9.2.6.5.2.2. Market
Forecast, 2022 - 2030
9.2.6.5.3. Asia Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2021
9.2.6.5.3.2. Market
Forecast, 2022 - 2030
9.2.6.5.4. Middle East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2021
9.2.6.5.4.2. Market
Forecast, 2022 - 2030
9.2.6.5.5. Latin America
9.2.6.5.5.1. Market
Estimation, 2015 - 2021
9.2.6.5.5.2. Market
Forecast, 2022 - 2030
9.2.7. Others
9.2.7.1. Definition
9.2.7.2. Market Estimation and Penetration, 2015 - 2021
9.2.7.3. Market Forecast, 2022 - 2030
9.2.7.4. Compound Annual Growth Rate (CAGR)
9.2.7.5. Regional Bifurcation
9.2.7.5.1. North America
9.2.7.5.1.1. Market
Estimation, 2015 - 2021
9.2.7.5.1.2. Market
Forecast, 2022 - 2030
9.2.7.5.2. Europe
9.2.7.5.2.1. Market
Estimation, 2015 - 2021
9.2.7.5.2.2. Market
Forecast, 2022 - 2030
9.2.7.5.3. Asia Pacific
9.2.7.5.3.1. Market
Estimation, 2015 - 2021
9.2.7.5.3.2. Market
Forecast, 2022 - 2030
9.2.7.5.4. Middle East and Africa
9.2.7.5.4.1. Market
Estimation, 2015 - 2021
9.2.7.5.4.2. Market
Forecast, 2022 - 2030
9.2.7.5.5. Latin America
9.2.7.5.5.1. Market
Estimation, 2015 - 2021
9.2.7.5.5.2. Market
Forecast, 2022 - 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Technology
10. Global Synthetic Biology Market Analysis and Forecasts, 2022
– 2030
10.1. Overview
10.2. Global
Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1. Food
and Beverages
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2021
10.2.1.3. Market Forecast, 2022 - 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2021
10.2.1.5.1.2. Market
Forecast, 2022 - 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2021
10.2.1.5.2.2. Market
Forecast, 2022 - 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2021
10.2.1.5.3.2. Market
Forecast, 2022 - 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2021
10.2.1.5.4.2. Market
Forecast, 2022 - 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2021
10.2.1.5.5.2. Market
Forecast, 2022 - 2030
10.2.2. Medical
Application (Definition, Market Estimation and Penetration, 2015 - 2021, Market
Estimation (2015 - 2021), Market Forecast (2022 - 2030), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Therapeutics, Drug
Discovery, Vaccine production, Life Science Research, Others)
10.2.2.1. Therapeutics
10.2.2.2. Drug Discovery
10.2.2.3. Vaccine production
10.2.2.4. Life Science Research
10.2.2.5. Others
10.2.3. Agriculture
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2021
10.2.3.3. Market Forecast, 2022 - 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2021
10.2.3.5.1.2. Market
Forecast, 2022 - 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2021
10.2.3.5.2.2. Market
Forecast, 2022 - 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2021
10.2.3.5.3.2. Market
Forecast, 2022 - 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2021
10.2.3.5.4.2. Market
Forecast, 2022 - 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2021
10.2.3.5.5.2. Market
Forecast, 2022 - 2030
10.2.4. Cosmetic
and Personal care
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2021
10.2.4.3. Market Forecast, 2022 - 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2021
10.2.4.5.1.2. Market
Forecast, 2022 - 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2021
10.2.4.5.2.2. Market
Forecast, 2022 - 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2021
10.2.4.5.3.2. Market
Forecast, 2022 - 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2021
10.2.4.5.4.2. Market
Forecast, 2022 - 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2021
10.2.4.5.5.2. Market
Forecast, 2022 - 2030
10.2.5. Industrial
and Automation
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2021
10.2.5.3. Market Forecast, 2022 - 2030
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2015 - 2021
10.2.5.5.1.2. Market
Forecast, 2022 - 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 - 2021
10.2.5.5.2.2. Market
Forecast, 2022 - 2030
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2015 - 2021
10.2.5.5.3.2. Market
Forecast, 2022 - 2030
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 - 2021
10.2.5.5.4.2. Market
Forecast, 2022 - 2030
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2015 - 2021
10.2.5.5.5.2. Market
Forecast, 2022 - 2030
10.2.6. Chemicals
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2015 - 2021
10.2.6.3. Market Forecast, 2022 - 2030
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market
Estimation, 2015 - 2021
10.2.6.5.1.2. Market
Forecast, 2022 - 2030
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2015 - 2021
10.2.6.5.2.2. Market
Forecast, 2022 - 2030
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market
Estimation, 2015 - 2021
10.2.6.5.3.2. Market
Forecast, 2022 - 2030
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market
Estimation, 2015 - 2021
10.2.6.5.4.2. Market
Forecast, 2022 - 2030
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market
Estimation, 2015 - 2021
10.2.6.5.5.2. Market
Forecast, 2022 - 2030
10.2.7. Renewable
Energy
10.2.7.1. Definition
10.2.7.2. Market Estimation and Penetration, 2015 - 2021
10.2.7.3. Market Forecast, 2022 - 2030
10.2.7.4. Compound Annual Growth Rate (CAGR)
10.2.7.5. Regional Bifurcation
10.2.7.5.1. North America
10.2.7.5.1.1. Market
Estimation, 2015 - 2021
10.2.7.5.1.2. Market
Forecast, 2022 - 2030
10.2.7.5.2. Europe
10.2.7.5.2.1. Market
Estimation, 2015 - 2021
10.2.7.5.2.2. Market
Forecast, 2022 - 2030
10.2.7.5.3. Asia Pacific
10.2.7.5.3.1. Market
Estimation, 2015 - 2021
10.2.7.5.3.2. Market
Forecast, 2022 - 2030
10.2.7.5.4. Middle East and Africa
10.2.7.5.4.1. Market
Estimation, 2015 - 2021
10.2.7.5.4.2. Market
Forecast, 2022 - 2030
10.2.7.5.5. Latin America
10.2.7.5.5.1. Market
Estimation, 2015 - 2021
10.2.7.5.5.2. Market
Forecast, 2022 - 2030
10.2.8. Environment
10.2.8.1. Definition
10.2.8.2. Market Estimation and Penetration, 2015 - 2021
10.2.8.3. Market Forecast, 2022 - 2030
10.2.8.4. Compound Annual Growth Rate (CAGR)
10.2.8.5. Regional Bifurcation
10.2.8.5.1. North America
10.2.8.5.1.1. Market
Estimation, 2015 - 2021
10.2.8.5.1.2. Market
Forecast, 2022 - 2030
10.2.8.5.2. Europe
10.2.8.5.2.1. Market
Estimation, 2015 - 2021
10.2.8.5.2.2. Market
Forecast, 2022 - 2030
10.2.8.5.3. Asia Pacific
10.2.8.5.3.1. Market
Estimation, 2015 - 2021
10.2.8.5.3.2. Market
Forecast, 2022 - 2030
10.2.8.5.4. Middle East and Africa
10.2.8.5.4.1. Market
Estimation, 2015 - 2021
10.2.8.5.4.2. Market
Forecast, 2022 - 2030
10.2.8.5.5. Latin America
10.2.8.5.5.1. Market
Estimation, 2015 - 2021
10.2.8.5.5.2. Market
Forecast, 2022 - 2030
10.2.9. Others
10.2.9.1. Definition
10.2.9.2. Market Estimation and Penetration, 2015 - 2021
10.2.9.3. Market Forecast, 2022 - 2030
10.2.9.4. Compound Annual Growth Rate (CAGR)
10.2.9.5. Regional Bifurcation
10.2.9.5.1. North America
10.2.9.5.1.1. Market
Estimation, 2015 - 2021
10.2.9.5.1.2. Market
Forecast, 2022 - 2030
10.2.9.5.2. Europe
10.2.9.5.2.1. Market
Estimation, 2015 - 2021
10.2.9.5.2.2. Market
Forecast, 2022 - 2030
10.2.9.5.3. Asia Pacific
10.2.9.5.3.1. Market
Estimation, 2015 - 2021
10.2.9.5.3.2. Market
Forecast, 2022 - 2030
10.2.9.5.4. Middle East and Africa
10.2.9.5.4.1. Market
Estimation, 2015 - 2021
10.2.9.5.4.2. Market
Forecast, 2022 - 2030
10.2.9.5.5. Latin America
10.2.9.5.5.1. Market
Estimation, 2015 - 2021
10.2.9.5.5.2. Market
Forecast, 2022 - 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. North America Synthetic Biology Market Analysis and
Forecasts, 2022 - 2030
11.1. Overview
11.1.1. North
America Synthetic Biology Market Revenue (US$ Mn)
11.2. North
America Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Offerings
11.2.1. Products/Systems
11.2.1.1. DNA synthesis
11.2.1.2. Enzymes
11.2.1.3. Gene Fragment
11.2.1.4. Algae Engineering Kits
11.2.1.5. Synthetic Cells
11.2.1.6. Others
11.2.2. Software
11.2.3. Services
11.3. North
America Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Technology
11.3.1. Cloning
11.3.2. Gene
synthesis
11.3.3. Microfluidic
11.3.4. Genome
Engineering
11.3.5. Site-Directed
Mutagenesis
11.3.6. Sequencing
11.3.7. Others
11.4. North
America Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Application
11.4.1. Food
and Beverages
11.4.2. Medical
Application
11.4.2.1. Therapeutics
11.4.2.2. Drug Discovery
11.4.2.3. Vaccine production
11.4.2.4. Life Science Research
11.4.2.5. Others
11.4.3. Agriculture
11.4.4. Cosmetic
and Personal care
11.4.5. Industrial
and Automation
11.4.6. Chemicals
11.4.7. Renewable
Energy
11.4.8. Environment
11.4.9. Others
11.5. North
America Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Offerings
11.5.1.1.1. Products/Systems
11.5.1.1.1.1. DNA
synthesis
11.5.1.1.1.2. Enzymes
11.5.1.1.1.3. Gene
Fragment
11.5.1.1.1.4. Algae
Engineering Kits
11.5.1.1.1.5. Synthetic
Cells
11.5.1.1.1.6. Others
11.5.1.1.2. Software
11.5.1.1.3. Services
11.5.1.2. U.S Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Technology
11.5.1.2.1. Cloning
11.5.1.2.2. Gene synthesis
11.5.1.2.3. Microfluidic
11.5.1.2.4. Genome Engineering
11.5.1.2.5. Site-Directed Mutagenesis
11.5.1.2.6. Sequencing
11.5.1.2.7. Others
11.5.1.3. U.S Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Application
11.5.1.3.1. Food and Beverages
11.5.1.3.2. Medical Application
11.5.1.3.2.1. Therapeutics
11.5.1.3.2.2. Drug
Discovery
11.5.1.3.2.3. Vaccine
production
11.5.1.3.2.4. Life
Science Research
11.5.1.3.2.5. Others
11.5.1.3.3. Agriculture
11.5.1.3.4. Cosmetic and Personal care
11.5.1.3.5. Industrial and Automation
11.5.1.3.6. Chemicals
11.5.1.3.7. Renewable Energy
11.5.1.3.8. Environment
11.5.1.3.9. Others
11.5.2. Canada
11.5.2.1. Canada Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.5.2.1.1. Products/Systems
11.5.2.1.1.1. DNA
synthesis
11.5.2.1.1.2. Enzymes
11.5.2.1.1.3. Gene
Fragment
11.5.2.1.1.4. Algae
Engineering Kits
11.5.2.1.1.5. Synthetic
Cells
11.5.2.1.1.6. Others
11.5.2.1.2. Software
11.5.2.1.3. Services
11.5.2.2. Canada Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Technology
11.5.2.2.1. Cloning
11.5.2.2.2. Gene synthesis
11.5.2.2.3. Microfluidic
11.5.2.2.4. Genome Engineering
11.5.2.2.5. Site-Directed Mutagenesis
11.5.2.2.6. Sequencing
11.5.2.2.7. Others
11.5.2.3. Canada Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.2.3.1. Food and Beverages
11.5.2.3.2. Medical Application
11.5.2.3.2.1. Therapeutics
11.5.2.3.2.2. Drug
Discovery
11.5.2.3.2.3. Vaccine
production
11.5.2.3.2.4. Life
Science Research
11.5.2.3.2.5. Others
11.5.2.3.3. Agriculture
11.5.2.3.4. Cosmetic and Personal care
11.5.2.3.5. Industrial and Automation
11.5.2.3.6. Chemicals
11.5.2.3.7. Renewable Energy
11.5.2.3.8. Environment
11.5.2.3.9. Others
11.5.3. Mexico
11.5.3.1. Mexico Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.5.3.1.1. Products/Systems
11.5.3.1.1.1. DNA
synthesis
11.5.3.1.1.2. Enzymes
11.5.3.1.1.3. Gene
Fragment
11.5.3.1.1.4. Algae
Engineering Kits
11.5.3.1.1.5. Synthetic
Cells
11.5.3.1.1.6. Others
11.5.3.1.2. Software
11.5.3.1.3. Services
11.5.3.2. Mexico Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
11.5.3.2.1. Cloning
11.5.3.2.2. Gene synthesis
11.5.3.2.3. Microfluidic
11.5.3.2.4. Genome Engineering
11.5.3.2.5. Site-Directed Mutagenesis
11.5.3.2.6. Sequencing
11.5.3.2.7. Others
11.5.3.3. Mexico Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.3.3.1. Food and Beverages
11.5.3.3.2. Medical Application
11.5.3.3.2.1. Therapeutics
11.5.3.3.2.2. Drug
Discovery
11.5.3.3.2.3. Vaccine
production
11.5.3.3.2.4. Life
Science Research
11.5.3.3.2.5. Others
11.5.3.3.3. Agriculture
11.5.3.3.4. Cosmetic and Personal care
11.5.3.3.5. Industrial and Automation
11.5.3.3.6. Chemicals
11.5.3.3.7. Renewable Energy
11.5.3.3.8. Environment
11.5.3.3.9. Others
11.5.4. Rest of
North America
11.5.4.1. Rest of North America Synthetic Biology Market Revenue (US$
Mn) and Forecasts, By Offerings
11.5.4.1.1. Products/Systems
11.5.4.1.1.1. DNA
synthesis
11.5.4.1.1.2. Enzymes
11.5.4.1.1.3. Gene
Fragment
11.5.4.1.1.4. Algae
Engineering Kits
11.5.4.1.1.5. Synthetic
Cells
11.5.4.1.1.6. Others
11.5.4.1.2. Software
11.5.4.1.3. Services
11.5.4.2. Rest of North America Synthetic Biology Market Revenue (US$
Mn) and Forecasts, By Technology
11.5.4.2.1. Cloning
11.5.4.2.2. Gene synthesis
11.5.4.2.3. Microfluidic
11.5.4.2.4. Genome Engineering
11.5.4.2.5. Site-Directed Mutagenesis
11.5.4.2.6. Sequencing
11.5.4.2.7. Others
11.5.4.3. Rest of North America Synthetic Biology Market Revenue (US$
Mn) and Forecasts, By Application
11.5.4.3.1. Food and Beverages
11.5.4.3.2. Medical Application
11.5.4.3.2.1. Therapeutics
11.5.4.3.2.2. Drug
Discovery
11.5.4.3.2.3. Vaccine
production
11.5.4.3.2.4. Life
Science Research
11.5.4.3.2.5. Others
11.5.4.3.3. Agriculture
11.5.4.3.4. Cosmetic and Personal care
11.5.4.3.5. Industrial and Automation
11.5.4.3.6. Chemicals
11.5.4.3.7. Renewable Energy
11.5.4.3.8. Environment
11.5.4.3.9. Others
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Offerings
11.6.3. By
Technology
11.6.4. By
Application
12. Europe Synthetic Biology Market Analysis and Forecasts, 2022
- 2030
12.1. Overview
12.1.1. Europe Synthetic
Biology Market Revenue (US$ Mn)
12.2. Europe
Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Offerings
12.2.1. Products/Systems
12.2.1.1. DNA synthesis
12.2.1.2. Enzymes
12.2.1.3. Gene Fragment
12.2.1.4. Algae Engineering Kits
12.2.1.5. Synthetic Cells
12.2.1.6. Others
12.2.2. Software
12.2.3. Services
12.3. Europe
Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Technology
12.3.1. Cloning
12.3.2. Gene
synthesis
12.3.3. Microfluidic
12.3.4. Genome
Engineering
12.3.5. Site-Directed
Mutagenesis
12.3.6. Sequencing
12.3.7. Others
12.4. Europe
Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Application
12.4.1. Food
and Beverages
12.4.2. Medical
Application
12.4.2.1. Therapeutics
12.4.2.2. Drug Discovery
12.4.2.3. Vaccine production
12.4.2.4. Life Science Research
12.4.2.5. Others
12.4.3. Agriculture
12.4.4. Cosmetic
and Personal care
12.4.5. Industrial
and Automation
12.4.6. Chemicals
12.4.7. Renewable
Energy
12.4.8. Environment
12.4.9. Others
12.5. Europe
Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.1.1.1. Products/Systems
12.5.1.1.1.1. DNA
synthesis
12.5.1.1.1.2. Enzymes
12.5.1.1.1.3. Gene
Fragment
12.5.1.1.1.4. Algae
Engineering Kits
12.5.1.1.1.5. Synthetic
Cells
12.5.1.1.1.6. Others
12.5.1.1.2. Software
12.5.1.1.3. Services
12.5.1.2. France Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
12.5.1.2.1. Cloning
12.5.1.2.2. Gene synthesis
12.5.1.2.3. Microfluidic
12.5.1.2.4. Genome Engineering
12.5.1.2.5. Site-Directed Mutagenesis
12.5.1.2.6. Sequencing
12.5.1.2.7. Others
12.5.1.3. France Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.1.3.1. Food and Beverages
12.5.1.3.2. Medical Application
12.5.1.3.2.1. Therapeutics
12.5.1.3.2.2. Drug
Discovery
12.5.1.3.2.3. Vaccine
production
12.5.1.3.2.4. Life
Science Research
12.5.1.3.2.5. Others
12.5.1.3.3. Agriculture
12.5.1.3.4. Cosmetic and Personal care
12.5.1.3.5. Industrial and Automation
12.5.1.3.6. Chemicals
12.5.1.3.7. Renewable Energy
12.5.1.3.8. Environment
12.5.1.3.9. Others
12.5.2. The UK
12.5.2.1. The UK Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.2.1.1. Products/Systems
12.5.2.1.1.1. DNA
synthesis
12.5.2.1.1.2. Enzymes
12.5.2.1.1.3. Gene
Fragment
12.5.2.1.1.4. Algae
Engineering Kits
12.5.2.1.1.5. Synthetic
Cells
12.5.2.1.1.6. Others
12.5.2.1.2. Software
12.5.2.1.3. Services
12.5.2.2. The UK Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
12.5.2.2.1. Cloning
12.5.2.2.2. Gene synthesis
12.5.2.2.3. Microfluidic
12.5.2.2.4. Genome Engineering
12.5.2.2.5. Site-Directed Mutagenesis
12.5.2.2.6. Sequencing
12.5.2.2.7. Others
12.5.2.3. The UK Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.2.3.1. Food and Beverages
12.5.2.3.2. Medical Application
12.5.2.3.2.1. Therapeutics
12.5.2.3.2.2. Drug
Discovery
12.5.2.3.2.3. Vaccine
production
12.5.2.3.2.4. Life
Science Research
12.5.2.3.2.5. Others
12.5.2.3.3. Agriculture
12.5.2.3.4. Cosmetic and Personal care
12.5.2.3.5. Industrial and Automation
12.5.2.3.6. Chemicals
12.5.2.3.7. Renewable Energy
12.5.2.3.8. Environment
12.5.2.3.9. Others
12.5.3. Spain
12.5.3.1. Spain Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Offerings
12.5.3.1.1. Products/Systems
12.5.3.1.1.1. DNA
synthesis
12.5.3.1.1.2. Enzymes
12.5.3.1.1.3. Gene
Fragment
12.5.3.1.1.4. Algae
Engineering Kits
12.5.3.1.1.5. Synthetic
Cells
12.5.3.1.1.6. Others
12.5.3.1.2. Software
12.5.3.1.3. Services
12.5.3.2. Spain Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Technology
12.5.3.2.1. Cloning
12.5.3.2.2. Gene synthesis
12.5.3.2.3. Microfluidic
12.5.3.2.4. Genome Engineering
12.5.3.2.5. Site-Directed Mutagenesis
12.5.3.2.6. Sequencing
12.5.3.2.7. Others
12.5.3.3. Spain Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Application
12.5.3.3.1. Food and Beverages
12.5.3.3.2. Medical Application
12.5.3.3.2.1. Therapeutics
12.5.3.3.2.2. Drug
Discovery
12.5.3.3.2.3. Vaccine
production
12.5.3.3.2.4. Life
Science Research
12.5.3.3.2.5. Others
12.5.3.3.3. Agriculture
12.5.3.3.4. Cosmetic and Personal care
12.5.3.3.5. Industrial and Automation
12.5.3.3.6. Chemicals
12.5.3.3.7. Renewable Energy
12.5.3.3.8. Environment
12.5.3.3.9. Others
12.5.4. Germany
12.5.4.1. Germany Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.4.1.1. Products/Systems
12.5.4.1.1.1. DNA
synthesis
12.5.4.1.1.2. Enzymes
12.5.4.1.1.3. Gene
Fragment
12.5.4.1.1.4. Algae
Engineering Kits
12.5.4.1.1.5. Synthetic
Cells
12.5.4.1.1.6. Others
12.5.4.1.2. Software
12.5.4.1.3. Services
12.5.4.2. Germany Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
12.5.4.2.1. Cloning
12.5.4.2.2. Gene synthesis
12.5.4.2.3. Microfluidic
12.5.4.2.4. Genome Engineering
12.5.4.2.5. Site-Directed Mutagenesis
12.5.4.2.6. Sequencing
12.5.4.2.7. Others
12.5.4.3. Germany Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.4.3.1. Food and Beverages
12.5.4.3.2. Medical Application
12.5.4.3.2.1. Therapeutics
12.5.4.3.2.2. Drug
Discovery
12.5.4.3.2.3. Vaccine
production
12.5.4.3.2.4. Life
Science Research
12.5.4.3.2.5. Others
12.5.4.3.3. Agriculture
12.5.4.3.4. Cosmetic and Personal care
12.5.4.3.5. Industrial and Automation
12.5.4.3.6. Chemicals
12.5.4.3.7. Renewable Energy
12.5.4.3.8. Environment
12.5.4.3.9. Others
12.5.5. Italy
12.5.5.1. Italy Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Offerings
12.5.5.1.1. Products/Systems
12.5.5.1.1.1. DNA
synthesis
12.5.5.1.1.2. Enzymes
12.5.5.1.1.3. Gene
Fragment
12.5.5.1.1.4. Algae
Engineering Kits
12.5.5.1.1.5. Synthetic
Cells
12.5.5.1.1.6. Others
12.5.5.1.2. Software
12.5.5.1.3. Services
12.5.5.2. Italy Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Technology
12.5.5.2.1. Cloning
12.5.5.2.2. Gene synthesis
12.5.5.2.3. Microfluidic
12.5.5.2.4. Genome Engineering
12.5.5.2.5. Site-Directed Mutagenesis
12.5.5.2.6. Sequencing
12.5.5.2.7. Others
12.5.5.3. Italy Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Application
12.5.5.3.1. Food and Beverages
12.5.5.3.2. Medical Application
12.5.5.3.2.1. Therapeutics
12.5.5.3.2.2. Drug
Discovery
12.5.5.3.2.3. Vaccine
production
12.5.5.3.2.4. Life
Science Research
12.5.5.3.2.5. Others
12.5.5.3.3. Agriculture
12.5.5.3.4. Cosmetic and Personal care
12.5.5.3.5. Industrial and Automation
12.5.5.3.6. Chemicals
12.5.5.3.7. Renewable Energy
12.5.5.3.8. Environment
12.5.5.3.9. Others
12.5.6. Nordic
Countries
12.5.6.1. Nordic Countries Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.6.1.1. Products/Systems
12.5.6.1.1.1. DNA
synthesis
12.5.6.1.1.2. Enzymes
12.5.6.1.1.3. Gene
Fragment
12.5.6.1.1.4. Algae
Engineering Kits
12.5.6.1.1.5. Synthetic
Cells
12.5.6.1.1.6. Others
12.5.6.1.2. Software
12.5.6.1.3. Services
12.5.6.2. Nordic Countries Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
12.5.6.2.1. Cloning
12.5.6.2.2. Gene synthesis
12.5.6.2.3. Microfluidic
12.5.6.2.4. Genome Engineering
12.5.6.2.5. Site-Directed Mutagenesis
12.5.6.2.6. Sequencing
12.5.6.2.7. Others
12.5.6.3. Nordic Countries Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.6.3.1. Food and Beverages
12.5.6.3.2. Medical Application
12.5.6.3.2.1. Therapeutics
12.5.6.3.2.2. Drug
Discovery
12.5.6.3.2.3. Vaccine
production
12.5.6.3.2.4. Life
Science Research
12.5.6.3.2.5. Others
12.5.6.3.3. Agriculture
12.5.6.3.4. Cosmetic and Personal care
12.5.6.3.5. Industrial and Automation
12.5.6.3.6. Chemicals
12.5.6.3.7. Renewable Energy
12.5.6.3.8. Environment
12.5.6.3.9. Others
12.5.6.4. Nordic Countries Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux Union Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.7.1.1. Products/Systems
12.5.7.1.1.1. DNA
synthesis
12.5.7.1.1.2. Enzymes
12.5.7.1.1.3. Gene
Fragment
12.5.7.1.1.4. Algae
Engineering Kits
12.5.7.1.1.5. Synthetic
Cells
12.5.7.1.1.6. Others
12.5.7.1.2. Software
12.5.7.1.3. Services
12.5.7.2. Benelux Union Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
12.5.7.2.1. Cloning
12.5.7.2.2. Gene synthesis
12.5.7.2.3. Microfluidic
12.5.7.2.4. Genome Engineering
12.5.7.2.5. Site-Directed Mutagenesis
12.5.7.2.6. Sequencing
12.5.7.2.7. Others
12.5.7.3. Benelux Union Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.7.3.1. Food and Beverages
12.5.7.3.2. Medical Application
12.5.7.3.2.1. Therapeutics
12.5.7.3.2.2. Drug
Discovery
12.5.7.3.2.3. Vaccine
production
12.5.7.3.2.4. Life
Science Research
12.5.7.3.2.5. Others
12.5.7.3.3. Agriculture
12.5.7.3.4. Cosmetic and Personal care
12.5.7.3.5. Industrial and Automation
12.5.7.3.6. Chemicals
12.5.7.3.7. Renewable Energy
12.5.7.3.8. Environment
12.5.7.3.9. Others
12.5.7.4. Benelux Union Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest of Europe Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
12.5.8.1.1. Products/Systems
12.5.8.1.1.1. DNA
synthesis
12.5.8.1.1.2. Enzymes
12.5.8.1.1.3. Gene
Fragment
12.5.8.1.1.4. Algae
Engineering Kits
12.5.8.1.1.5. Synthetic
Cells
12.5.8.1.1.6. Others
12.5.8.1.2. Software
12.5.8.1.3. Services
12.5.8.2. Rest of Europe Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
12.5.8.2.1. Cloning
12.5.8.2.2. Gene synthesis
12.5.8.2.3. Microfluidic
12.5.8.2.4. Genome Engineering
12.5.8.2.5. Site-Directed Mutagenesis
12.5.8.2.6. Sequencing
12.5.8.2.7. Others
12.5.8.3. Rest of Europe Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
12.5.8.3.1. Food and Beverages
12.5.8.3.2. Medical Application
12.5.8.3.2.1. Therapeutics
12.5.8.3.2.2. Drug
Discovery
12.5.8.3.2.3. Vaccine
production
12.5.8.3.2.4. Life
Science Research
12.5.8.3.2.5. Others
12.5.8.3.3. Agriculture
12.5.8.3.4. Cosmetic and Personal care
12.5.8.3.5. Industrial and Automation
12.5.8.3.6. Chemicals
12.5.8.3.7. Renewable Energy
12.5.8.3.8. Environment
12.5.8.3.9. Others
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Offerings
12.6.3. By
Technology
12.6.4. By
Application
13. Asia Pacific Synthetic Biology Market Analysis and Forecasts,
2022 - 2030
13.1. Overview
13.1.1. Asia
Pacific Synthetic Biology Market Revenue (US$ Mn)
13.2. Asia
Pacific Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Offerings
13.2.1. Products/Systems
13.2.1.1. DNA synthesis
13.2.1.2. Enzymes
13.2.1.3. Gene Fragment
13.2.1.4. Algae Engineering Kits
13.2.1.5. Synthetic Cells
13.2.1.6. Others
13.2.2. Software
13.2.3. Services
13.3. Asia
Pacific Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Technology
13.3.1. Cloning
13.3.2. Gene
synthesis
13.3.3. Microfluidic
13.3.4. Genome
Engineering
13.3.5. Site-Directed
Mutagenesis
13.3.6. Sequencing
13.3.7. Others
13.4. Asia
Pacific Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1. Food
and Beverages
13.4.2. Medical
Application
13.4.2.1. Therapeutics
13.4.2.2. Drug Discovery
13.4.2.3. Vaccine production
13.4.2.4. Life Science Research
13.4.2.5. Others
13.4.3. Agriculture
13.4.4. Cosmetic
and Personal care
13.4.5. Industrial
and Automation
13.4.6. Chemicals
13.4.7. Renewable
Energy
13.4.8. Environment
13.4.9. Others
13.5. Asia
Pacific Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Offerings
13.5.1.1.1. Products/Systems
13.5.1.1.1.1. DNA
synthesis
13.5.1.1.1.2. Enzymes
13.5.1.1.1.3. Gene
Fragment
13.5.1.1.1.4. Algae
Engineering Kits
13.5.1.1.1.5. Synthetic
Cells
13.5.1.1.1.6. Others
13.5.1.1.2. Software
13.5.1.1.3. Services
13.5.1.2. China Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Technology
13.5.1.2.1. Cloning
13.5.1.2.2. Gene synthesis
13.5.1.2.3. Microfluidic
13.5.1.2.4. Genome Engineering
13.5.1.2.5. Site-Directed Mutagenesis
13.5.1.2.6. Sequencing
13.5.1.2.7. Others
13.5.1.3. China Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Application
13.5.1.3.1. Food and Beverages
13.5.1.3.2. Medical Application
13.5.1.3.2.1. Therapeutics
13.5.1.3.2.2. Drug
Discovery
13.5.1.3.2.3. Vaccine
production
13.5.1.3.2.4. Life
Science Research
13.5.1.3.2.5. Others
13.5.1.3.3. Agriculture
13.5.1.3.4. Cosmetic and Personal care
13.5.1.3.5. Industrial and Automation
13.5.1.3.6. Chemicals
13.5.1.3.7. Renewable Energy
13.5.1.3.8. Environment
13.5.1.3.9. Others
13.5.2. Japan
13.5.2.1. Japan Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Offerings
13.5.2.1.1. Products/Systems
13.5.2.1.1.1. DNA
synthesis
13.5.2.1.1.2. Enzymes
13.5.2.1.1.3. Gene
Fragment
13.5.2.1.1.4. Algae
Engineering Kits
13.5.2.1.1.5. Synthetic
Cells
13.5.2.1.1.6. Others
13.5.2.1.2. Software
13.5.2.1.3. Services
13.5.2.2. Japan Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Technology
13.5.2.2.1. Cloning
13.5.2.2.2. Gene synthesis
13.5.2.2.3. Microfluidic
13.5.2.2.4. Genome Engineering
13.5.2.2.5. Site-Directed Mutagenesis
13.5.2.2.6. Sequencing
13.5.2.2.7. Others
13.5.2.3. Japan Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Application
13.5.2.3.1. Food and Beverages
13.5.2.3.2. Medical Application
13.5.2.3.2.1. Therapeutics
13.5.2.3.2.2. Drug
Discovery
13.5.2.3.2.3. Vaccine
production
13.5.2.3.2.4. Life
Science Research
13.5.2.3.2.5. Others
13.5.2.3.3. Agriculture
13.5.2.3.4. Cosmetic and Personal care
13.5.2.3.5. Industrial and Automation
13.5.2.3.6. Chemicals
13.5.2.3.7. Renewable Energy
13.5.2.3.8. Environment
13.5.2.3.9. Others
13.5.3. India
13.5.3.1. India Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Offerings
13.5.3.1.1. Products/Systems
13.5.3.1.1.1. DNA
synthesis
13.5.3.1.1.2. Enzymes
13.5.3.1.1.3. Gene
Fragment
13.5.3.1.1.4. Algae
Engineering Kits
13.5.3.1.1.5. Synthetic
Cells
13.5.3.1.1.6. Others
13.5.3.1.2. Software
13.5.3.1.3. Services
13.5.3.2. India Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Technology
13.5.3.2.1. Cloning
13.5.3.2.2. Gene synthesis
13.5.3.2.3. Microfluidic
13.5.3.2.4. Genome Engineering
13.5.3.2.5. Site-Directed Mutagenesis
13.5.3.2.6. Sequencing
13.5.3.2.7. Others
13.5.3.3. India Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Application
13.5.3.3.1. Food and Beverages
13.5.3.3.2. Medical Application
13.5.3.3.2.1. Therapeutics
13.5.3.3.2.2. Drug
Discovery
13.5.3.3.2.3. Vaccine
production
13.5.3.3.2.4. Life
Science Research
13.5.3.3.2.5. Others
13.5.3.3.3. Agriculture
13.5.3.3.4. Cosmetic and Personal care
13.5.3.3.5. Industrial and Automation
13.5.3.3.6. Chemicals
13.5.3.3.7. Renewable Energy
13.5.3.3.8. Environment
13.5.3.3.9. Others
13.5.4. New
Zealand
13.5.4.1. New Zealand Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.4.1.1. Products/Systems
13.5.4.1.1.1. DNA
synthesis
13.5.4.1.1.2. Enzymes
13.5.4.1.1.3. Gene
Fragment
13.5.4.1.1.4. Algae
Engineering Kits
13.5.4.1.1.5. Synthetic
Cells
13.5.4.1.1.6. Others
13.5.4.1.2. Software
13.5.4.1.3. Services
13.5.4.2. New Zealand Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
13.5.4.2.1. Cloning
13.5.4.2.2. Gene synthesis
13.5.4.2.3. Microfluidic
13.5.4.2.4. Genome Engineering
13.5.4.2.5. Site-Directed Mutagenesis
13.5.4.2.6. Sequencing
13.5.4.2.7. Others
13.5.4.3. New Zealand Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.4.3.1. Food and Beverages
13.5.4.3.2. Medical Application
13.5.4.3.2.1. Therapeutics
13.5.4.3.2.2. Drug
Discovery
13.5.4.3.2.3. Vaccine
production
13.5.4.3.2.4. Life
Science Research
13.5.4.3.2.5. Others
13.5.4.3.3. Agriculture
13.5.4.3.4. Cosmetic and Personal care
13.5.4.3.5. Industrial and Automation
13.5.4.3.6. Chemicals
13.5.4.3.7. Renewable Energy
13.5.4.3.8. Environment
13.5.4.3.9. Others
13.5.5. Australia
13.5.5.1. Australia Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.5.1.1. Products/Systems
13.5.5.1.1.1. DNA
synthesis
13.5.5.1.1.2. Enzymes
13.5.5.1.1.3. Gene
Fragment
13.5.5.1.1.4. Algae
Engineering Kits
13.5.5.1.1.5. Synthetic
Cells
13.5.5.1.1.6. Others
13.5.5.1.2. Software
13.5.5.1.3. Services
13.5.5.2. Australia Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
13.5.5.2.1. Cloning
13.5.5.2.2. Gene synthesis
13.5.5.2.3. Microfluidic
13.5.5.2.4. Genome Engineering
13.5.5.2.5. Site-Directed Mutagenesis
13.5.5.2.6. Sequencing
13.5.5.2.7. Others
13.5.5.3. Australia Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.5.3.1. Food and Beverages
13.5.5.3.2. Medical Application
13.5.5.3.2.1. Therapeutics
13.5.5.3.2.2. Drug
Discovery
13.5.5.3.2.3. Vaccine
production
13.5.5.3.2.4. Life
Science Research
13.5.5.3.2.5. Others
13.5.5.3.3. Agriculture
13.5.5.3.4. Cosmetic and Personal care
13.5.5.3.5. Industrial and Automation
13.5.5.3.6. Chemicals
13.5.5.3.7. Renewable Energy
13.5.5.3.8. Environment
13.5.5.3.9. Others
13.5.6. South
Korea
13.5.6.1. South Korea Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.6.1.1. Products/Systems
13.5.6.1.1.1. DNA
synthesis
13.5.6.1.1.2. Enzymes
13.5.6.1.1.3. Gene
Fragment
13.5.6.1.1.4. Algae
Engineering Kits
13.5.6.1.1.5. Synthetic
Cells
13.5.6.1.1.6. Others
13.5.6.1.2. Software
13.5.6.1.3. Services
13.5.6.2. South Korea Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
13.5.6.2.1. Cloning
13.5.6.2.2. Gene synthesis
13.5.6.2.3. Microfluidic
13.5.6.2.4. Genome Engineering
13.5.6.2.5. Site-Directed Mutagenesis
13.5.6.2.6. Sequencing
13.5.6.2.7. Others
13.5.6.3. South Korea Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
13.5.6.3.1. Food and Beverages
13.5.6.3.2. Medical Application
13.5.6.3.2.1. Therapeutics
13.5.6.3.2.2. Drug
Discovery
13.5.6.3.2.3. Vaccine
production
13.5.6.3.2.4. Life
Science Research
13.5.6.3.2.5. Others
13.5.6.3.3. Agriculture
13.5.6.3.4. Cosmetic and Personal care
13.5.6.3.5. Industrial and Automation
13.5.6.3.6. Chemicals
13.5.6.3.7. Renewable Energy
13.5.6.3.8. Environment
13.5.6.3.9. Others
13.5.7. Southeast
Asia
13.5.7.1. Southeast Asia Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.7.1.1. Products/Systems
13.5.7.1.1.1. DNA
synthesis
13.5.7.1.1.2. Enzymes
13.5.7.1.1.3. Gene
Fragment
13.5.7.1.1.4. Algae
Engineering Kits
13.5.7.1.1.5. Synthetic
Cells
13.5.7.1.1.6. Others
13.5.7.1.2. Software
13.5.7.1.3. Services
13.5.7.2. Southeast Asia Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
13.5.7.2.1. Cloning
13.5.7.2.2. Gene synthesis
13.5.7.2.3. Microfluidic
13.5.7.2.4. Genome Engineering
13.5.7.2.5. Site-Directed Mutagenesis
13.5.7.2.6. Sequencing
13.5.7.2.7. Others
13.5.7.3. Southeast Asia Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Application
13.5.7.3.1. Food and Beverages
13.5.7.3.2. Medical Application
13.5.7.3.2.1. Therapeutics
13.5.7.3.2.2. Drug
Discovery
13.5.7.3.2.3. Vaccine
production
13.5.7.3.2.4. Life
Science Research
13.5.7.3.2.5. Others
13.5.7.3.3. Agriculture
13.5.7.3.4. Cosmetic and Personal care
13.5.7.3.5. Industrial and Automation
13.5.7.3.6. Chemicals
13.5.7.3.7. Renewable Energy
13.5.7.3.8. Environment
13.5.7.3.9. Others
13.5.7.4. Southeast Asia Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest of Asia Pacific Synthetic Biology Market Revenue (US$ Mn)
and Forecasts, By Offerings
13.5.8.1.1. Products/Systems
13.5.8.1.1.1. DNA
synthesis
13.5.8.1.1.2. Enzymes
13.5.8.1.1.3. Gene
Fragment
13.5.8.1.1.4. Algae
Engineering Kits
13.5.8.1.1.5. Synthetic
Cells
13.5.8.1.1.6. Others
13.5.8.1.2. Software
13.5.8.1.3. Services
13.5.8.2. Rest of Asia Pacific Synthetic Biology Market Revenue (US$ Mn)
and Forecasts, By Technology
13.5.8.2.1. Cloning
13.5.8.2.2. Gene synthesis
13.5.8.2.3. Microfluidic
13.5.8.2.4. Genome Engineering
13.5.8.2.5. Site-Directed Mutagenesis
13.5.8.2.6. Sequencing
13.5.8.2.7. Others
13.5.8.3. Rest of Asia Pacific Synthetic Biology Market Revenue (US$ Mn)
and Forecasts, By Application
13.5.8.3.1. Food and Beverages
13.5.8.3.2. Medical Application
13.5.8.3.2.1. Therapeutics
13.5.8.3.2.2. Drug
Discovery
13.5.8.3.2.3. Vaccine
production
13.5.8.3.2.4. Life
Science Research
13.5.8.3.2.5. Others
13.5.8.3.3. Agriculture
13.5.8.3.4. Cosmetic and Personal care
13.5.8.3.5. Industrial and Automation
13.5.8.3.6. Chemicals
13.5.8.3.7. Renewable Energy
13.5.8.3.8. Environment
13.5.8.3.9. Others
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Offerings
13.6.3. By
Technology
13.6.4. By
Application
14. Middle East and Africa Synthetic Biology Market Analysis and
Forecasts, 2022 - 2030
14.1. Overview
14.1.1. Middle
East and Africa Synthetic Biology Market Revenue (US$ Mn)
14.2. Middle
East and Africa Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By
Offerings
14.2.1. Products/Systems
14.2.1.1. DNA synthesis
14.2.1.2. Enzymes
14.2.1.3. Gene Fragment
14.2.1.4. Algae Engineering Kits
14.2.1.5. Synthetic Cells
14.2.1.6. Others
14.2.2. Software
14.2.3. Services
14.3. Middle
East and Africa Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By
Technology
14.3.1. Cloning
14.3.2. Gene
synthesis
14.3.3. Microfluidic
14.3.4. Genome
Engineering
14.3.5. Site-Directed
Mutagenesis
14.3.6. Sequencing
14.3.7. Others
14.4. Middle
East and Africa Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By
Application
14.4.1. Food
and Beverages
14.4.2. Medical
Application
14.4.2.1. Therapeutics
14.4.2.2. Drug Discovery
14.4.2.3. Vaccine production
14.4.2.4. Life Science Research
14.4.2.5. Others
14.4.3. Agriculture
14.4.4. Cosmetic
and Personal care
14.4.5. Industrial
and Automation
14.4.6. Chemicals
14.4.7. Renewable
Energy
14.4.8. Environment
14.4.9. Others
14.5. Middle
East and Africa Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By
Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi Arabia Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.5.1.1.1. Products/Systems
14.5.1.1.1.1. DNA
synthesis
14.5.1.1.1.2. Enzymes
14.5.1.1.1.3. Gene
Fragment
14.5.1.1.1.4. Algae
Engineering Kits
14.5.1.1.1.5. Synthetic
Cells
14.5.1.1.1.6. Others
14.5.1.1.2. Software
14.5.1.1.3. Services
14.5.1.2. Saudi Arabia Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
14.5.1.2.1. Cloning
14.5.1.2.2. Gene synthesis
14.5.1.2.3. Microfluidic
14.5.1.2.4. Genome Engineering
14.5.1.2.5. Site-Directed Mutagenesis
14.5.1.2.6. Sequencing
14.5.1.2.7. Others
14.5.1.3. Saudi Arabia Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.1.3.1. Food and Beverages
14.5.1.3.2. Medical Application
14.5.1.3.2.1. Therapeutics
14.5.1.3.2.2. Drug
Discovery
14.5.1.3.2.3. Vaccine
production
14.5.1.3.2.4. Life
Science Research
14.5.1.3.2.5. Others
14.5.1.3.3. Agriculture
14.5.1.3.4. Cosmetic and Personal care
14.5.1.3.5. Industrial and Automation
14.5.1.3.6. Chemicals
14.5.1.3.7. Renewable Energy
14.5.1.3.8. Environment
14.5.1.3.9. Others
14.5.2. UAE
14.5.2.1. UAE Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Offerings
14.5.2.1.1. Products/Systems
14.5.2.1.1.1. DNA
synthesis
14.5.2.1.1.2. Enzymes
14.5.2.1.1.3. Gene
Fragment
14.5.2.1.1.4. Algae
Engineering Kits
14.5.2.1.1.5. Synthetic
Cells
14.5.2.1.1.6. Others
14.5.2.1.2. Software
14.5.2.1.3. Services
14.5.2.2. UAE Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Technology
14.5.2.2.1. Cloning
14.5.2.2.2. Gene synthesis
14.5.2.2.3. Microfluidic
14.5.2.2.4. Genome Engineering
14.5.2.2.5. Site-Directed Mutagenesis
14.5.2.2.6. Sequencing
14.5.2.2.7. Others
14.5.2.3. UAE Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Application
14.5.2.3.1. Food and Beverages
14.5.2.3.2. Medical Application
14.5.2.3.2.1. Therapeutics
14.5.2.3.2.2. Drug
Discovery
14.5.2.3.2.3. Vaccine
production
14.5.2.3.2.4. Life
Science Research
14.5.2.3.2.5. Others
14.5.2.3.3. Agriculture
14.5.2.3.4. Cosmetic and Personal care
14.5.2.3.5. Industrial and Automation
14.5.2.3.6. Chemicals
14.5.2.3.7. Renewable Energy
14.5.2.3.8. Environment
14.5.2.3.9. Others
14.5.3. Egypt
14.5.3.1. Egypt Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Offerings
14.5.3.1.1. Products/Systems
14.5.3.1.1.1. DNA
synthesis
14.5.3.1.1.2. Enzymes
14.5.3.1.1.3. Gene
Fragment
14.5.3.1.1.4. Algae
Engineering Kits
14.5.3.1.1.5. Synthetic
Cells
14.5.3.1.1.6. Others
14.5.3.1.2. Software
14.5.3.1.3. Services
14.5.3.2. Egypt Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Technology
14.5.3.2.1. Cloning
14.5.3.2.2. Gene synthesis
14.5.3.2.3. Microfluidic
14.5.3.2.4. Genome Engineering
14.5.3.2.5. Site-Directed Mutagenesis
14.5.3.2.6. Sequencing
14.5.3.2.7. Others
14.5.3.3. Egypt Synthetic Biology Market Revenue (US$ Mn) and Forecasts,
By Application
14.5.3.3.1. Food and Beverages
14.5.3.3.2. Medical Application
14.5.3.3.2.1. Therapeutics
14.5.3.3.2.2. Drug
Discovery
14.5.3.3.2.3. Vaccine
production
14.5.3.3.2.4. Life
Science Research
14.5.3.3.2.5. Others
14.5.3.3.3. Agriculture
14.5.3.3.4. Cosmetic and Personal care
14.5.3.3.5. Industrial and Automation
14.5.3.3.6. Chemicals
14.5.3.3.7. Renewable Energy
14.5.3.3.8. Environment
14.5.3.3.9. Others
14.5.4. Kuwait
14.5.4.1. Kuwait Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.5.4.1.1. Products/Systems
14.5.4.1.1.1. DNA
synthesis
14.5.4.1.1.2. Enzymes
14.5.4.1.1.3. Gene
Fragment
14.5.4.1.1.4. Algae
Engineering Kits
14.5.4.1.1.5. Synthetic
Cells
14.5.4.1.1.6. Others
14.5.4.1.2. Software
14.5.4.1.3. Services
14.5.4.2. Kuwait Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
14.5.4.2.1. Cloning
14.5.4.2.2. Gene synthesis
14.5.4.2.3. Microfluidic
14.5.4.2.4. Genome Engineering
14.5.4.2.5. Site-Directed Mutagenesis
14.5.4.2.6. Sequencing
14.5.4.2.7. Others
14.5.4.3. Kuwait Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.4.3.1. Food and Beverages
14.5.4.3.2. Medical Application
14.5.4.3.2.1. Therapeutics
14.5.4.3.2.2. Drug
Discovery
14.5.4.3.2.3. Vaccine
production
14.5.4.3.2.4. Life
Science Research
14.5.4.3.2.5. Others
14.5.4.3.3. Agriculture
14.5.4.3.4. Cosmetic and Personal care
14.5.4.3.5. Industrial and Automation
14.5.4.3.6. Chemicals
14.5.4.3.7. Renewable Energy
14.5.4.3.8. Environment
14.5.4.3.9. Others
14.5.5. South
Africa
14.5.5.1. South Africa Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.5.5.1.1. Products/Systems
14.5.5.1.1.1. DNA
synthesis
14.5.5.1.1.2. Enzymes
14.5.5.1.1.3. Gene
Fragment
14.5.5.1.1.4. Algae
Engineering Kits
14.5.5.1.1.5. Synthetic
Cells
14.5.5.1.1.6. Others
14.5.5.1.2. Software
14.5.5.1.3. Services
14.5.5.2. South Africa Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
14.5.5.2.1. Cloning
14.5.5.2.2. Gene synthesis
14.5.5.2.3. Microfluidic
14.5.5.2.4. Genome Engineering
14.5.5.2.5. Site-Directed Mutagenesis
14.5.5.2.6. Sequencing
14.5.5.2.7. Others
14.5.5.3. South Africa Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.5.3.1. Food and Beverages
14.5.5.3.2. Medical Application
14.5.5.3.2.1. Therapeutics
14.5.5.3.2.2. Drug
Discovery
14.5.5.3.2.3. Vaccine
production
14.5.5.3.2.4. Life
Science Research
14.5.5.3.2.5. Others
14.5.5.3.3. Agriculture
14.5.5.3.4. Cosmetic and Personal care
14.5.5.3.5. Industrial and Automation
14.5.5.3.6. Chemicals
14.5.5.3.7. Renewable Energy
14.5.5.3.8. Environment
14.5.5.3.9. Others
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest of Middle East & Africa Synthetic Biology Market
Revenue (US$ Mn) and Forecasts, By Offerings
14.5.6.1.1. Products/Systems
14.5.6.1.1.1. DNA
synthesis
14.5.6.1.1.2. Enzymes
14.5.6.1.1.3. Gene
Fragment
14.5.6.1.1.4. Algae
Engineering Kits
14.5.6.1.1.5. Synthetic
Cells
14.5.6.1.1.6. Others
14.5.6.1.2. Software
14.5.6.1.3. Services
14.5.6.2. Rest of Middle East & Africa Synthetic Biology Market
Revenue (US$ Mn) and Forecasts, By Technology
14.5.6.2.1. Cloning
14.5.6.2.2. Gene synthesis
14.5.6.2.3. Microfluidic
14.5.6.2.4. Genome Engineering
14.5.6.2.5. Site-Directed Mutagenesis
14.5.6.2.6. Sequencing
14.5.6.2.7. Others
14.5.6.3. Rest of Middle East & Africa Synthetic Biology Market
Revenue (US$ Mn) and Forecasts, By Application
14.5.6.3.1. Food and Beverages
14.5.6.3.2. Medical Application
14.5.6.3.2.1. Therapeutics
14.5.6.3.2.2. Drug
Discovery
14.5.6.3.2.3. Vaccine
production
14.5.6.3.2.4. Life
Science Research
14.5.6.3.2.5. Others
14.5.6.3.3. Agriculture
14.5.6.3.4. Cosmetic and Personal care
14.5.6.3.5. Industrial and Automation
14.5.6.3.6. Chemicals
14.5.6.3.7. Renewable Energy
14.5.6.3.8. Environment
14.5.6.3.9. Others
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Offerings
14.6.3. By
Technology
14.6.4. By
Application
15. Latin America Synthetic Biology Market Analysis and
Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Latin
America Synthetic Biology Market Revenue (US$ Mn)
15.2. Latin
America Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Offerings
15.2.1. Products/Systems
15.2.1.1. DNA synthesis
15.2.1.2. Enzymes
15.2.1.3. Gene Fragment
15.2.1.4. Algae Engineering Kits
15.2.1.5. Synthetic Cells
15.2.1.6. Others
15.2.2. Software
15.2.3. Services
15.3. Latin America
Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Technology
15.3.1. Cloning
15.3.2. Gene
synthesis
15.3.3. Microfluidic
15.3.4. Genome
Engineering
15.3.5. Site-Directed
Mutagenesis
15.3.6. Sequencing
15.3.7. Others
15.4. Latin
America Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1. Food
and Beverages
15.4.2. Medical
Application
15.4.2.1. Therapeutics
15.4.2.2. Drug Discovery
15.4.2.3. Vaccine production
15.4.2.4. Life Science Research
15.4.2.5. Others
15.4.3. Agriculture
15.4.4. Cosmetic
and Personal care
15.4.5. Industrial
and Automation
15.4.6. Chemicals
15.4.7. Renewable
Energy
15.4.8. Environment
15.4.9. Others
15.5. Latin
America Synthetic Biology Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.5.1.1.1. Products/Systems
15.5.1.1.1.1. DNA
synthesis
15.5.1.1.1.2. Enzymes
15.5.1.1.1.3. Gene
Fragment
15.5.1.1.1.4. Algae
Engineering Kits
15.5.1.1.1.5. Synthetic
Cells
15.5.1.1.1.6. Others
15.5.1.1.2. Software
15.5.1.1.3. Services
15.5.1.2. Brazil Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
15.5.1.2.1. Cloning
15.5.1.2.2. Gene synthesis
15.5.1.2.3. Microfluidic
15.5.1.2.4. Genome Engineering
15.5.1.2.5. Site-Directed Mutagenesis
15.5.1.2.6. Sequencing
15.5.1.2.7. Others
15.5.1.3. Brazil Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
15.5.1.3.1. Food and Beverages
15.5.1.3.2. Medical Application
15.5.1.3.2.1. Therapeutics
15.5.1.3.2.2. Drug
Discovery
15.5.1.3.2.3. Vaccine
production
15.5.1.3.2.4. Life
Science Research
15.5.1.3.2.5. Others
15.5.1.3.3. Agriculture
15.5.1.3.4. Cosmetic and Personal care
15.5.1.3.5. Industrial and Automation
15.5.1.3.6. Chemicals
15.5.1.3.7. Renewable Energy
15.5.1.3.8. Environment
15.5.1.3.9. Others
15.5.2. Argentina
15.5.2.1. Argentina Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.5.2.1.1. Products/Systems
15.5.2.1.1.1. DNA
synthesis
15.5.2.1.1.2. Enzymes
15.5.2.1.1.3. Gene
Fragment
15.5.2.1.1.4. Algae
Engineering Kits
15.5.2.1.1.5. Synthetic
Cells
15.5.2.1.1.6. Others
15.5.2.1.2. Software
15.5.2.1.3. Services
15.5.2.2. Argentina Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Technology
15.5.2.2.1. Cloning
15.5.2.2.2. Gene synthesis
15.5.2.2.3. Microfluidic
15.5.2.2.4. Genome Engineering
15.5.2.2.5. Site-Directed Mutagenesis
15.5.2.2.6. Sequencing
15.5.2.2.7. Others
15.5.2.3. Argentina Synthetic Biology Market Revenue (US$ Mn) and
Forecasts, By Application
15.5.2.3.1. Food and Beverages
15.5.2.3.2. Medical Application
15.5.2.3.2.1. Therapeutics
15.5.2.3.2.2. Drug
Discovery
15.5.2.3.2.3. Vaccine
production
15.5.2.3.2.4. Life
Science Research
15.5.2.3.2.5. Others
15.5.2.3.3. Agriculture
15.5.2.3.4. Cosmetic and Personal care
15.5.2.3.5. Industrial and Automation
15.5.2.3.6. Chemicals
15.5.2.3.7. Renewable Energy
15.5.2.3.8. Environment
15.5.2.3.9. Others
15.5.3. Rest of
Latin America
15.5.3.1. Rest of Latin America Synthetic Biology Market Revenue (US$
Mn) and Forecasts, By Offerings
15.5.3.1.1. Products/Systems
15.5.3.1.1.1. DNA
synthesis
15.5.3.1.1.2. Enzymes
15.5.3.1.1.3. Gene
Fragment
15.5.3.1.1.4. Algae
Engineering Kits
15.5.3.1.1.5. Synthetic
Cells
15.5.3.1.1.6. Others
15.5.3.1.2. Software
15.5.3.1.3. Services
15.5.3.2. Rest of Latin America Synthetic Biology Market Revenue (US$
Mn) and Forecasts, By Technology
15.5.3.2.1. Cloning
15.5.3.2.2. Gene synthesis
15.5.3.2.3. Microfluidic
15.5.3.2.4. Genome Engineering
15.5.3.2.5. Site-Directed Mutagenesis
15.5.3.2.6. Sequencing
15.5.3.2.7. Others
15.5.3.3. Rest of Latin America Synthetic Biology Market Revenue (US$
Mn) and Forecasts, By Application
15.5.3.3.1. Food and Beverages
15.5.3.3.2. Medical Application
15.5.3.3.2.1. Therapeutics
15.5.3.3.2.2. Drug
Discovery
15.5.3.3.2.3. Vaccine
production
15.5.3.3.2.4. Life
Science Research
15.5.3.3.2.5. Others
15.5.3.3.3. Agriculture
15.5.3.3.4. Cosmetic and Personal care
15.5.3.3.5. Industrial and Automation
15.5.3.3.6. Chemicals
15.5.3.3.7. Renewable Energy
15.5.3.3.8. Environment
15.5.3.3.9. Others
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Offerings
15.6.3. By
Technology
15.6.4. By
Application
16. Competitive Benchmarking
16.1. Brand
Benchmarking
16.2. Market
Share Analysis, 2021
16.3. Global
Presence and Growth Strategies
16.3.1. Mergers
and Acquisitions
16.3.2. Product
Launches
16.3.3. Investments
Trends
16.3.4. R&D
Initiatives
17. Player Profiles
17.1. Agilent
Technologies, Inc.
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. Amyris
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business Strategies
17.3. Arzeda
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business Strategies
17.4. Codexis, Inc.
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business Strategies
17.5. GenScript
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business Strategies
17.6. Ginkgo Bioworks
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business Strategies
17.7. Illumina, Inc.
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business Strategies
17.8. Intrexon Corporation
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business Strategies
17.9. Royal Dutch Shell
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business Strategies
17.10. String Bio
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT Analysis
17.10.7. Business Strategies
17.11. SynbiCITE
17.11.1. Company
Details
17.11.2. Company
Overview
17.11.3. Product
Offerings
17.11.4. Key
Developments
17.11.5. Financial
Analysis
17.11.6. SWOT
Analysis
17.11.7. Business Strategies
17.12. Thermo Fisher Scientific
17.12.1. Company
Details
17.12.2. Company
Overview
17.12.3. Product
Offerings
17.12.4. Key
Developments
17.12.5. Financial
Analysis
17.12.6. SWOT
Analysis
17.12.7. Business Strategies
17.13. Twist Bioscience
17.13.1. Company
Details
17.13.2. Company
Overview
17.13.3. Product
Offerings
17.13.4. Key
Developments
17.13.5. Financial
Analysis
17.13.6. SWOT
Analysis
17.13.7. Business Strategies
17.14. ZYMERGEN INC.
17.14.1. Company
Details
17.14.2. Company
Overview
17.14.3. Product
Offerings
17.14.4. Key
Developments
17.14.5. Financial
Analysis
17.14.6. SWOT
Analysis
17.14.7. Business Strategies
17.15. Other Market Participants
18. Key Findings
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.